Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

- 1 min read

Aiolos Bio Launches with $245M Series A Investment

San Francisco and London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. officially launches as a clinical-stage biopharmaceutical company, committed to addressing unmet medical needs in respiratory and inflammatory conditions. The company secures an oversubscribed $245 million in Series A funding.

Read full article here.

Comments

Life Science Headlines

Siemens Healthineers to Acquire Novartis' Diagnostic Arm for $244M Expanding PET Imaging Capabilities

BioAesthetics Appoints Dr. Juliana Blum as CEO to Drive Advancement of Innovative Graft Technology

Getinge to Acquire U.S. Organ Transport Firm Paragonix Technologies for $477M

Christian Howell Appointed as CEO of Cognito Therapeutics, Poised to Advance Alzheimer’s Therapy Development

Johnson & Johnson Expands Heart Disease Device Portfolio with $1.7B V-Wave Deal

Crown Laboratories and Revance Therapeutics announce $924M Merger

Sernova Corp. appoints Jonathan Rigby as new CEO to lead innovative regenerative medicine efforts

Sangamo Therapeutics and Genentech Forge $1.9B License Agreement for Novel Neurodegenerative Disease Treatments

BD Names Michael Feld to the Helm of Life Sciences Division

Baxter Sells Kidney Care Segment to Carlyle for $3.8B in Strategic Realignment